Navigation Links
BioMarin Announces Third Quarter 2010 Financial Results
Date:10/28/2010

Previous 2010 GuidanceCost of Sales (% of Total Revenue)

Unchanged

19% to 20%Selling, General and Admin. Expense*

$147 to $152

$145 to $150Research and Development Expense*

$147 to $152

$140 to $145Amortization and Contingent Consideration

$8 to $9

NAInterest Income

$4

$3 to $4 GAAP Net Income (Loss)**

$213 to $218

$(6) to $2Stock Compensation Expense

Unchanged

$37Non-GAAP Net Income

$28 to $33

$30 to $38*  Previous guidance did not include $5.0 million to $7.0 million in additional operating expenses associated with the acquisition of ZyStor Therapeutics, Inc.**  Includes $223.1 million resulting from reversal of deferred tax asset valuation allowanceAnticipated Upcoming Milestones4Q 2010: File IND for BMN-673 (PARP inhibitor)December 2010/ January 2011: Initiation of Phase 1 trial for BMN-701 for Pompe diseaseEarly 2011: Initiation of pivotal Phase III trial for Firdapse for LEMS in the U.S.Early 1Q 2011: Initiation of pivotal Phase III trial for GALNS for MPS IVA1Q 2011: Initiation of Phase Ib trial for BMN-673 (PARP inhibitor)Mid-2011: Final top-line results from PEG-PAL Phase II trial, including daily dosing and formulation studiesLate 2011: Availability of blood Phe monitor4Q 2011/1Q 2012: Initiation of Phase III PEG-PAL trial1Q 2012: Initiation of Phase I trial for BMN-111 for Achondroplasia1H 2012: NDA filing for Firdapse for LEMS in the U.S.4Q 2012: Approval of Firdapse for LEMS in the U.S.4Q 2012: U.S. and European filings for GALNS for MPS IVAResearch and Development ProgramsBioMarin continues to make significant investments in research and development to ensure continued growth of the company.  The current pipeline includes programs which are in various stages of development and are focused on treating a range of unmet medical needs.Advanced Programs

  • Firdapse: BioMarin expects to initiate a Phase III trial f
    '/>"/>

  • SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. BioMarin to Host a Research and Development Day on October 19th
    2. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
    3. BioMarin to Present at the UBS Global Life Sciences Conference
    4. BioMarin to Present at the Stifel Nicolaus Healthcare Conference
    5. BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
    6. BioMarin Acquires ZyStor Therapeutics, Inc.
    7. BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
    8. BioMarin to Acquire LEAD Therapeutics
    9. BioMarin to Present at the Credit Suisse Healthcare Conference
    10. BioMarin Announces Third Quarter 2009 Financial Results
    11. BioMarin to Present at the Oppenheimer Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... Dec. 18, 2014   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... positive results from its pivotal field study of ... pain in dogs with osteoarthritis.  In the study, ... scores that were statistically significant compared to placebo ...
    (Date:12/19/2014)... separating membrane market has witnessed robust development with ... albeit as a later starter. In 2012, the size of ... RMB12 billion, with the proportion worldwide soaring to 16.3%. It ... market will continue its growth rate by around 20% in ... jump to roughly RMB25 billion. An integrated membrane ...
    (Date:12/17/2014)... December 17, 2014 Los beneficios ... un alto nivel de gasto en investigación y desarrollo ... (finalizado el 30 de septiembre de 2014) ZEISS aumentó ... millones de euros (año anterior: 4.190 millones de euros) ... Las ganancias (EBIT) crecieron un 14 por ciento, a ...
    Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS confirma su posición en un entorno difícil 2
    ... ALTO, Calif., Oct. 1 Telik, Inc. (Nasdaq: TELK ... a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination ... nonsmall cell lung cancer (NSCLC) in a leading peer reviewed ... Vol. 4, No. 10. Data on this study were ...
    ... , MOUNTAIN VIEW, Calif., Oct. 1 IRIDEX Corporation ... FlexFiber(TM) a laser fiber probe intended for effective delivery ... procedures. Introduced at the 2009 American Academy of ... , this consumable product represents an increase in IRIDEX, ...
    Cached Medicine Technology:Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer 2IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting 2
    (Date:12/20/2014)... The holidays can be anything but joyous for people ... candles and other allergy triggers. "The dust from ... packed away in dank basements or dusty attics is ... Rachna Shah, an affiliate faculty member at Loyola University ... release. Shah, who is also an allergist at ...
    (Date:12/20/2014)... 20, 2014 The Doctor’s Office Urgent Care ... better part of a decade. They’ve treated over 40,000 ... faster healthcare alternative to the Paramus area. ... new additions to their staff of top-notch board certified physicians: ... MD. These new doctors will work tirelessly to ...
    (Date:12/20/2014)... New York (PRWEB) December 20, 2014 ... continue to move forward in U.S. courts, Bernstein ... study which suggests that children treated with the ... hormone linked to breast development and lactation. The ... at 34 children and adolescents who began treatment ...
    (Date:12/20/2014)... 20, 2014 The aftermath of the November ... stir, not only in Hollywood, but worldwide. As ... the ripples of that attack are starting a finger-pointing game ... risk. But they are not the only ones affected, ... in for some embarrassing times ahead, agents and lawyers could ...
    (Date:12/20/2014)... 2014 Developers of FCPX ... new plugin for Final Cut Pro X entitled TranSlice ... 5 allows users to create hand drawn text animations ... Austin, CEO of Pixel Film Studios. “TranSlice Volume 5 ... maintaining an easy to use interface.” , TranSlice Volume ...
    Breaking Medicine News(10 mins):Health News:Holiday Trimmings Can Trigger Allergies 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
    ... for the marathon continues to improve for both men and ... now about as fast as the record pace for the ... are running more than four times farther at speeds of ... this be? Are humans simply built better or is there ...
    ... AMERIGROUP Foundation, the,philanthropic arm of AMERIGROUP Corporation, honored ... at a ceremony today at,the University of Maryland ... Vince Ancona presented a,contribution in the amount of ... Breathmobile is a custom-built pediatric asthma and,allergy clinic ...
    ... HealthSouth,Corporation (NYSE: HLS ) has finalized, ... previously announced purchase of The Rehabilitation,Hospital of ... in,Vineland, NJ, from The Mediplex/Cumberland Rehabilitation Limited,Partnership., ... under the outstanding,leadership of Dr. Francis Bonner, ...
    ... and often fatal, researchers say, , , THURSDAY, July 31 (HealthDay ... dissection could lead to a rapid diagnostic test for this ... is a tear in the lining of the aorta, the ... of the body. About 2,000 people a year in North ...
    ... may make women more susceptible to contracting HIV, the virus ... School of Public Health researchers have found. , An analysis ... women from around the world, showed that women with bacterial ... of reproductive age were more likely than others to ...
    ... Late summer and early fall,are prime seasons for ... Nile Virus and EEE by health departments and ... list of 2008 cases,reported in your area:, http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount08_detailed.htm ... action and help your family and pets by,installing ...
    Cached Medicine News:Health News:Story ideas for health reporters covering the summer Olympic Games 2Health News:Story ideas for health reporters covering the summer Olympic Games 3Health News:Story ideas for health reporters covering the summer Olympic Games 4Health News:Story ideas for health reporters covering the summer Olympic Games 5Health News:Story ideas for health reporters covering the summer Olympic Games 6Health News:The AMERIGROUP Foundation Honors the University of Maryland Hospital for Children's Breathmobile 2Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 2Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 3Health News:Gene Test Could Catch Deadly Heart Problem 2Health News:Gene Test Could Catch Deadly Heart Problem 3Health News:UNC study: Common vaginal infection may increase risk of HIV infection 2Health News:Season for West Nile Virus/EEE Reportings Begin; Mosquito Vacuum Helps Reduce Backyard Mosquito Population 2
    Reusable, stainless steel trephine with handle....
    Reusable, stainless steel trephine with handle....
    Reusable, stainless steel trephine with handle....
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Medicine Products: